Structure

InChI Key MMNNTJYFHUDSKL-UHFFFAOYSA-N
Smiles COC(=O)Nc1nc2cc(C3(O)c4ccccc4C(=O)N3c3cc(Cl)ccc3C)ccc2[nH]1
InChI
InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)

Physicochemical Descriptors

Property Name Value
Molecular Formula C24H19ClN4O4
Molecular Weight 462.89
AlogP 4.56
Hydrogen Bond Acceptor 5.0
Hydrogen Bond Donor 3.0
Number of Rotational Bond 3.0
Polar Surface Area 107.55
Molecular species NEUTRAL
Aromatic Rings 4.0
Heavy Atoms 33.0

Bioactivity

Mechanism of Action Action Reference
Serine/threonine-protein kinase B-raf inhibitor INHIBITOR PubMed Other Other PubMed
Protein: Serine/threonine-protein kinase RAF

Description: RAF proto-oncogene serine/threonine-protein kinase

Organism : Homo sapiens

P04049 ENSG00000132155
Protein: Serine/threonine-protein kinase B-raf

Description: Serine/threonine-protein kinase B-raf

Organism : Homo sapiens

P15056 ENSG00000157764
Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Kinase Protein Kinase TKL protein kinase group TKL protein kinase RAF family
- 6-2000 - - -
Assay Description Organism Bioactivity Reference
Inhibition of BRAF V600E mutant (unknown origin) Homo sapiens 6.0 nM
Cytotoxicity against human SK-MEL-19 cells harboring BRAF mutant after 3 days Homo sapiens 200.0 nM

Cross References

Resources Reference
ChEMBL CHEMBL3545027
DrugBank DB12854
FDA SRS DW2NWI3TFN
Guide to Pharmacology 7968
SureChEMBL SCHEMBL10049428